Impact of cardiovascular risk enrichment on incidence of major adverse cardiovascular events in the tofacitinib rheumatoid arthritis clinical programme

A tétel rövid nézete
dc.contributor.authorDougados, Maxime
dc.contributor.authorCharles-Schoeman, Christina
dc.contributor.authorSzekanecz, Zoltán
dc.contributor.authorGiles, Jon T.
dc.contributor.authorYtterberg, Steven R.
dc.contributor.authorBhatt, Deepak L.
dc.contributor.authorKoch, Gary G.
dc.contributor.authorVranic, Ivana
dc.contributor.authorWu, Joseph
dc.contributor.authorWang, Cunshan
dc.contributor.authorKwok, Kenneth
dc.contributor.authorMenon, Sujatha
dc.contributor.authorConnell, Carol A.
dc.contributor.authorYndestad, Arne
dc.contributor.authorRivas, Jose L.
dc.contributor.authorBuch, Maya H.
dc.date.accessioned2023-02-02T13:15:44Z
dc.date.available2023-02-02T13:15:44Z
dc.date.issued2023
dc.date.oa2024-03-28
dc.date.pasync2023-08-14T23:06:20Z
dc.date.updated2023-02-02T13:15:44Z
dc.description.correctorLB
dc.identifier.citationAnnals Of The Rheumatic Diseases. -82 : 4 (2023), p. 575-577. -Ann. Rheum. Dis. - 0003-4967
dc.identifier.doihttp://dx.doi.org/10.1136/ard-2022-223406
dc.identifier.issn0003-4967
dc.identifier.opachttps://ebib.lib.unideb.hu/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM108307
dc.identifier.scopus85148667393
dc.identifier.urihttps://hdl.handle.net/2437/345382
dc.identifier.urlhttps://ard.bmj.com/lookup/doi/10.1136/ard-2022-223406
dc.identifier.wos000926215100001
dc.languageeng
dc.rights.accessopen access article
dc.subject.mabOrvostudományok
dc.subject.mabKlinikai orvostudományok
dc.titleImpact of cardiovascular risk enrichment on incidence of major adverse cardiovascular events in the tofacitinib rheumatoid arthritis clinical programme
dc.typefolyóiratcikk
dc.typelevél
Fájlok
Eredeti köteg (ORIGINAL bundle)
Megjelenítve 1 - 1 (Összesen 1)
Nincs kép
Név:
FILE_UP_1_Impact.pdf
Méret:
284.53 KB
Formátum:
Adobe Portable Document Format
Leírás:
Kiadói változat
Letöltés
Gyűjtemények
Publikációs Adatbázis